Enhancing olfactory receptor expression for biochemical studies of odorant-receptor interactions
增强嗅觉受体表达以进行气味受体相互作用的生化研究
基本信息
- 批准号:10465009
- 负责人:
- 金额:$ 68.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-01 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAffinityAgonistAmino Acid SequenceBackBindingBinding SitesBiochemicalBiochemistryBiological AssayCarrier ProteinsCell LineCell surfaceCellsChargeChemicalsCollaborationsCommunitiesComputing MethodologiesCryoelectron MicroscopyDataDetergentsDevelopmentDockingElectron MicroscopyEngineeringEventEvolutionFamilyFamily memberFoundationsG-Protein-Coupled ReceptorsGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsGoalsGrantHumanIn VitroInterdisciplinary StudyKidneyKnowledgeLigand BindingLigandsMachine LearningMalignant NeoplasmsMapsMediatingModelingMolecularNoseOdorant ReceptorsOdorsOlfactory PathwaysOutcomePhysiologyProductionPropertyProstateProtein FamilyProtein Sequence AnalysisPublishingRecombinantsRoleSignal TransductionSkinSmell PerceptionStructural ModelsStructureSystemTechniquesTechnologyTestingTissuesWorkantagonistbasechemical bindingcryogenicsdesignexperienceexperimental studyfeedingimprovedinnovationinsightlarge scale productionmolecular modelingmutantnovelnovel strategiesolfactory receptoroverexpressionpredictive testprotein purificationreceptorreceptor bindingreceptor expressionreceptor functionsmall moleculestructural biologysuccessthermostabilitytool
项目摘要
Summary:
Title: Enhancing olfactory receptor expression for biochemical studies of odorant-
receptor interactions
Our sense of smell is mediated by olfactory receptors (ORs), which are the largest family
of G protein-coupled receptors (GPCRs). Some ORs also function outside the nose to
coordinate important physiology; OR function has been shown to be important in kidney,
skin, prostate, and in multiple cancer tissues. Despite groundbreaking advances in
delineating the structural basis of GPCR action, ORs remain among the most
unexplored class GPCRs in terms of structure, ligand binding and activation mechanism.
This is primarily because: 1) low expression of ORs in heterologous cell lines impedes
structure-function studies and 2) we lack small molecules that can potently activate and
inhibit OR function. In the past two years, Matsunami and Vaidehi have uncovered
amino acid sequence evolution and structural properties that contribute to OR
expression. Simultaneously, Matsunami and Manglik used engineered ORs with
enhanced expression to validate new approaches to purify ORs in detergents for
structural and biochemical studies. Building on these successes, we propose to address
fundamental challenges in OR expression and ligand discovery in iterative predict-test
cycles combining novel computational methods and experimental testing with two aims.
In Aim 1, we propose to engineer mutant ORs for six human ORs to enable
overexpression of these receptors for in vitro studies and tractability for large-scale
purification in detergents. In Aim 2, we will map OR ligand binding sites and discover
new high affinity agonists and antagonists using a combination of structural modeling,
ligand docking and biochemical experiments. We will also develop approaches to
determine structures of active ORs bound to odorants and G proteins by cryo-EM. The
outcome of the proposed work will provide new foundations to interrogate OR function
and widely available computational approaches to accelerate the OR field.
简介:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aashish Manglik其他文献
Aashish Manglik的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aashish Manglik', 18)}}的其他基金
Mechanisms of Smoothened Activation in Hedgehog Signaling
Hedgehog 信号传导平滑激活机制
- 批准号:
10365068 - 财政年份:2022
- 资助金额:
$ 68.86万 - 项目类别:
Mechanisms of Smoothened Activation in Hedgehog Signaling
Hedgehog 信号传导平滑激活机制
- 批准号:
10552682 - 财政年份:2022
- 资助金额:
$ 68.86万 - 项目类别:
Enhancing olfactory receptor expression for biochemical studies of odorant-receptor interactions
增强嗅觉受体表达以进行气味受体相互作用的生化研究
- 批准号:
10580041 - 财政年份:2022
- 资助金额:
$ 68.86万 - 项目类别:
Precision pharmacology by local control of opioid receptors in neural circuits
通过局部控制神经回路中的阿片受体实现精准药理学
- 批准号:
10219227 - 财政年份:2020
- 资助金额:
$ 68.86万 - 项目类别:
Precision pharmacology by local control of opioid receptors in neural circuits
通过局部控制神经回路中的阿片受体实现精准药理学
- 批准号:
10405103 - 财政年份:2020
- 资助金额:
$ 68.86万 - 项目类别:
Biochemical approaches to enlighten GPR85 function
生化方法揭示 GPR85 功能
- 批准号:
10047548 - 财政年份:2020
- 资助金额:
$ 68.86万 - 项目类别:
Precision pharmacology by local control of opioid receptors in neural circuits
通过局部控制神经回路中的阿片受体实现精准药理学
- 批准号:
10044383 - 财政年份:2020
- 资助金额:
$ 68.86万 - 项目类别:
相似海外基金
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10412227 - 财政年份:2022
- 资助金额:
$ 68.86万 - 项目类别:
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10610473 - 财政年份:2022
- 资助金额:
$ 68.86万 - 项目类别:
Supplement to Discovery of a high affinity, selective and beta-arrestinbiased 5-HT7R Agonist Grant
对高亲和力、选择性和 β 抑制偏向 5-HT7R 激动剂发现的补充补助金
- 批准号:
10799162 - 财政年份:2022
- 资助金额:
$ 68.86万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6639179 - 财政年份:2001
- 资助金额:
$ 68.86万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6724797 - 财政年份:2001
- 资助金额:
$ 68.86万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6636512 - 财政年份:2001
- 资助金额:
$ 68.86万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6326889 - 财政年份:2001
- 资助金额:
$ 68.86万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6266928 - 财政年份:2001
- 资助金额:
$ 68.86万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6539099 - 财政年份:2001
- 资助金额:
$ 68.86万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6520329 - 财政年份:2001
- 资助金额:
$ 68.86万 - 项目类别:














{{item.name}}会员




